Related Experiment Video
Updated: Feb 7, 2026

Administration of Δ9-Tetrahydrocannabinol (THC) in Adolescent and Adult Mice
Published on: August 1, 2025
Persistent Opioid Use Among Children, Adolescents, and Young Adults After Common Cleft Operations
Katelyn G Bennett1, Calista M Harbaugh2, Hsou Mei Hu1
1Section of Plastic Surgery.
Insights
New persistent opioid use after cleft surgery affects 4.4% of pediatric patients, potentially leading to chronic opioid dependence. Risk factors include distractor placement, increasing age, and gastrointestinal comorbidities.
Area of Science:
- Pediatric Surgery
- Pain Management
- Opioid Prescribing Practices
Background:
- Surgical procedures are a significant contributor to opioid initiation and chronic use.
- Rates of prolonged opioid use following pediatric surgeries are not well-established.
- This study investigates new persistent opioid use after common cleft operations.
Purpose of the Study:
- To determine the incidence of new persistent opioid use after cleft-related procedures in young patients.
- To identify risk factors associated with prolonged opioid use post-pediatric surgery.
- To understand the potential transition from acute to chronic opioid use in this population.
Main Methods:
- Analysis of claims data from the Truven Marketscan databases (2010-2014).
- Inclusion of opioid-naive patients (ages 8-25) undergoing one of ten cleft procedures.
- Comparison with age-matched, non-surgical control patients.
Main Results:
- New persistent opioid use was observed in 4.4% of cleft patients versus 0.1% in controls.
- Distractor placement (OR 5.34) was significantly associated with increased opioid use.
- Increasing age (OR 1.11) and gastrointestinal comorbidities (OR 7.37) were also identified as risk factors.
Conclusions:
- New persistent opioid use is a notable outcome following cleft-related surgical procedures.
- This pattern of use in children, adolescents, and young adults may signify a pathway to chronic opioid dependence.
- Identifying risk factors is crucial for mitigating long-term opioid use.
Background:
Surgical care represents an important source of opioid prescribing and chronic use, but rates of prolonged opioid use following pediatric procedures remain unclear. The authors describe the rates and risk factors for new persistent opioid use in patients after common cleft operations.
Methods:
The authors examined claims from the Truven Marketscan databases from January 1, 2010 to December 31, 2014. The authors included opioid-naive patients ages 8 to 25, who underwent 1 of 10 cleft-related procedures. Patients were considered opioid-naïve if they had no opioid prescription fills in the 11 months prior to the perioperative period. The authors obtained a random sample of age-matched, nonsurgical patients from the same dataset to be used as a control group. Included cleft patients had no procedural codes in the 6 months following surgery. All included patients filled an opioid prescription during the perioperative period, defined as 30 days before and 14 days after surgery. The primary outcome was new persistent opioid use, which is defined as continued opioid prescription fills between 90 and 180 days after the procedure.
Results:
This cohort included 2039 cleft patients and 2100 control patients. The incidence of new persistent opioid use following surgery was 4.4% and 0.1% in the control group. Higher odds of opioid use 3 months beyond surgery were associated with distractor placement (OR 5.34, CI 2.00-14.24, P = 0.001). Increasing age (OR 1.11, CI 1.04-1.17, P = 0.001) and presence of a gastrointestinal comorbidity (OR 7.37, CI 1.49-36.54, P = 0.014) were also associated with new persistent use.
Conclusions:
New persistent opioid use occurs after cleft-related procedures and could lead to chronic use in children, adolescents, and young adults.
Related Concept Videos
Revisionist Views of Adolescent and Adult Cognition
Opioid Analgesics: Synthetic and Semisynthetic Opioids
Opioid Receptors: Overview
Common Ion Effect
Cognitive Development During Adolescence
Opioid Analgesics: Morphine and Other Natural Cogeners

